Prevention of AD With Stoma
Neurogenic bowel dysfunction is increasingly recognized as a major barrier to increasing quality of life in people with SCI. Bowel management difficulties include constipation, abdominal pain, faecal incontinence, prolonged transit time, and AD. The treatment of neurogenic bowel dysfunction with stoma usually takes place when other interventions such as transanal irrigation, pharmacological agents, etc. have failed.
One cross-sectional study (n=92) completed a retrospective analysis participants who had stomas. Following stoma surgery, significantly fewer respondents reported AD associated with bowel management (37% before, 18% after).
There is level 4 evidence (Coggrave et al. 2012) that AD associated with bowel management decreases following stoma surgery.